← Open Payments lookup

MELINA SIMS: Open Payments

NPI 1851096903 · SURPRISE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,154 in 64 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $1,170 · 2025 $2,154

Food & beverage: $2,154
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP14$792
ABBVIE INC.16$433
Astellas Pharma US Inc3$186
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$175
Novo Nordisk Inc8$163
Sumitomo Pharma America, Inc.4$99
Corcept Therapeutics3$97
Amgen Inc.4$60
Aimmune Therapeutics, Inc.2$53
Phathom Pharmaceuticals, Inc.1$22

Products named: BREZTRI, VRAYLAR, AIRSUPRA, Veozah, CAPLYTA, FARXIGA, GEMTESA, Korlym.

Industry payments across AZ — which companies pay providers there.